Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(10): 001-007


Anti-mycobacterial assessment and characterization of 5-O-caffeoylquinic acid methyl ester and rutin from Pavetta crassipes

Patricia O. Odumosu, William John Lough, Davis Yakubu, Keith Thomas, Gemma Williamson, Nicolas Haroune.




Abstract

Pavetta crassipes leaf (Fam. Rubiaceae) is used as part of a combination herbal remedy for the treatment of tuberculosis (TB) and other respiratory infections in Nigerian ethno medicine. However, little scientific data is available to support the use in ethnomedical therapy so the objective of the study was to assess the anti-tubercular property and to identify the bioactive components. The dried powdered leaf was sequentially extracted with solvents to obtain hexane, dichloromethane, methanol and water extracts. Following which, the extracts were then screened against Mycobacterium aurum, a rapidly growing saprophytic mycobacterium species for activity. The methanol extract exhibited inhibitory activity at an MIC value of 250 µg/mL against M. aurum and two known polyphenolic compounds were isolated as 5-O-caffeoylquinic acid methyl ester and quercetin-3-rutinoside (rutin). Reversed phase semi-preparative HPLC, mass spectrometry and 1H and 13C NMR techniques were utilized in isolating and characterizing the two components. The assignments of the structures were consistent with data from the literature. The study has shown that the methanol extract has some activity and hyphenation of LC-MS can be used for the isolation of polyphenols from the methanol fraction without a rigorous purification process.

Key words: Ethno medicine, M. aurum, polyphenols, reversed phase semi-preparative HPLC, LC-MS, tuberculosis.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.